Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative-Allogeneic Hematopoietic Cell Transplantation
Bradbury CA., Ward J., Vyas P., Russell NH., David G., Hills RK., Burnett AK., Craddock CF., Sylvie F.